Geode Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,029,780
Closed -$8.53M 4883
2023
Q1
$8.53M Buy
2,029,780
+116,026
+6% +$602K ﹤0.01% 2355
2022
Q4
$11.5M Buy
1,913,754
+134,785
+8% +$736K ﹤0.01% 2166
2022
Q3
$10.4M Buy
1,778,969
+190,422
+12% +$1.19M ﹤0.01% 2224
2022
Q2
$9.48M Buy
1,588,547
+810,931
+104% +$4.15M ﹤0.01% 2285
2022
Q1
$3.63M Buy
777,616
+94,990
+14% +$283K ﹤0.01% 2967
2021
Q4
$1.69M Buy
682,626
+23,800
+4% +$58.2K ﹤0.01% 3456
2021
Q3
$1.94M Buy
658,826
+69,676
+12% +$190K ﹤0.01% 3363
2021
Q2
$1.47M Buy
589,150
+106,502
+22% +$255K ﹤0.01% 3408
2021
Q1
$1.4M Buy
482,648
+51,567
+12% +$168K ﹤0.01% 3417
2020
Q4
$1.39M Buy
431,081
+14,644
+4% +$48.7K ﹤0.01% 3257
2020
Q3
$895K Sell
416,437
-7,148
-2% -$9.13K ﹤0.01% 3256
2020
Q2
$491K Buy
423,585
+7,572
+2% +$8K ﹤0.01% 3389
2020
Q1
$382K Buy
416,013
+14,270
+4% +$16.4K ﹤0.01% 3351
2019
Q4
$634K Sell
401,743
-48,011
-11% -$45.5K ﹤0.01% 3434
2019
Q3
$374K Sell
449,754
-6,900
-2% -$5.27K ﹤0.01% 3572
2019
Q2
$392K Sell
456,654
-174,459
-28% -$161K ﹤0.01% 3554
2019
Q1
$612K Sell
631,113
-1,614
-0.3% -$1.7K ﹤0.01% 3352
2018
Q4
$464K Buy
632,727
+5,214
+0.8% +$8.57K ﹤0.01% 3400
2018
Q3
$1.35M Buy
627,513
+114,290
+22% +$283K ﹤0.01% 3090
2018
Q2
$2.56M Buy
513,223
+209,994
+69% +$919K ﹤0.01% 2718
2018
Q1
$1.18M Buy
303,229
+183,842
+154% +$647K ﹤0.01% 3045
2017
Q4
$319K Sell
119,387
-75,298
-39% -$221K ﹤0.01% 3517
2017
Q3
$620K Buy
194,685
+81,003
+71% +$271K ﹤0.01% 3285
2017
Q2
$376K Sell
113,682
-3,838
-3% -$14.9K ﹤0.01% 3449
2017
Q1
$493K Buy
117,520
+520
+0.4% +$2.4K ﹤0.01% 3316
2016
Q4
$472K Buy
117,000
+3,696
+3% +$15.3K ﹤0.01% 3284
2016
Q3
$424K Buy
113,304
+146
+0.1% +$532 ﹤0.01% 3316
2016
Q2
$384K Sell
113,158
-18,950
-14% -$87K ﹤0.01% 3331
2016
Q1
$702 Buy
132,108
+22,034
+20% +$176K ﹤0.01% 3063
2015
Q4
$1.35M Buy
110,074
+11,240
+11% +$150K ﹤0.01% 2741
2015
Q3
$1.44M Buy
98,834
+3,620
+4% +$62.6K ﹤0.01% 2651
2015
Q2
$1.86M Buy
95,214
+6,746
+8% +$130K ﹤0.01% 2548
2015
Q1
$1.6M Buy
88,468
+6,894
+8% +$155K ﹤0.01% 2582
2014
Q4
$1.93M Buy
81,574
+1,723
+2% +$39.8K ﹤0.01% 2461
2014
Q3
$1.93M Buy
79,851
+5,122
+7% +$133K ﹤0.01% 2376
2014
Q2
$2.1M Buy
74,729
+840
+1% +$25.2K ﹤0.01% 2346
2014
Q1
$2.51M Buy
73,889
+13,696
+23% +$468K ﹤0.01% 2205
2013
Q4
$1.16M Buy
60,193
+22,159
+58% +$403K ﹤0.01% 2629
2013
Q3
$624K Buy
38,034
+10,595
+39% +$123K ﹤0.01% 2836
2013
Q2
$288K Buy
+27,439
New +$322K ﹤0.01% 3100

Other funds holding CTIC